The RAS-RAF-MEK-extracellular-regulated kinase (RAS/ERK) pathway is a major intracellular route used by metazoan cells to channel to downstream targets a diverse array of signals, including those controlling cell proliferation and survival. Recent findings suggest that the pathway is assembled by specific scaffolding proteins that in turn regulate the efficiency, the location and/or the duration of signal transmission. Here, through the angle of studies conducted in Drosophila and C. elegans, we present two such proteins, the kinase suppressor of RAS (KSR) and connector enhancer of KSR (CNK) scaffolds, and highlight their implication in a novel mechanism regulating RAS-mediated RAF activation. Based on recent findings, we discuss the possibility that KSR, a RAF-like protein, does not solely act as a scaffold, but directly induces RAF catalytic function by a kinaseindependent mechanism apparently shared by RAF-like proteins.
Introduction
Mitogen-activated protein kinase (MAPK) pathways correspond to modules of three kinases (a MAPKKK, a MAPKK and a MAPK) transmitting incoming signals to specific intracellular destinations via an internal phosphorylation cascade. In mammals, five distinct MAPK modules have been identified (Schaeffer and Weber, 1999) . Among these stands the evolutionarily conserved extracellular-regulated kinase (ERK) pathway that comprises specific isoforms of RAF (MAPKKK), MEK (MAPKK) and ERK (MAPK) and transduces critical signals affecting cell proliferation, differentiation and survival (Widmann et al., 1999; Pearson et al., 2001; Torii et al., 2004) . Most of our knowledge surrounding the activation of the ERK module has been derived from work conducted on receptor tyrosine kinases (RTKs), although other classes of membrane receptors also signal through it (Chang et al., 2003; Werry et al., 2006) . A major consequence following RTK activation by growth factors is guanosine triphosphate (GTP) loading of the small GTPase RAS, which as a result triggers the activation of a number of downstream effector proteins including the Ser/Thr-kinase RAF. Once activated, RAF phosphorylates and activates MEK, which in turn phosphorylates and activates ERK (English et al., 1999; Pearson et al., 2001) . Given the key role often played by this pathway in tumorigenesis, considerable efforts have been devoted to describe in molecular terms the signal-transduction events taking place within the ERK module. In that respect, the use of genetically tractable simpler metazoans, such as Drosophila or C. elegans, has proven to be instrumental in identifying novel components of the module and provided valuable insights on its inner workings. Here, we review the role of two constituents of the ERK module that regulate the pathway at the level of RAF, namely kinase suppressor of RAS (KSR) and connector enhancer of KSR (CNK), as illustrated by studies conducted in flies and worms. First, we provide a brief overview of RAF proteins and their mode of activation.
RAF proteins
Mammals express three distinct RAF isoforms known as A-RAF, B-RAF and C-RAF/Raf-1. In contrast, Drosophila and C. elegans have a single RAF-encoding gene, respectively known as polehole (d-raf) and lin-45 (Wellbrock et al., 2004) . RAF proteins contain three conserved regions (CR1-3; Figure 1a ). The CR1 serves to localize the proteins to the plasma membrane. It comprises a RAS-binding domain (RBD) adjacent to a cysteine-rich domain (CRD) that presumably associates with a membrane lipid following growth factor stimulation (Huwiler et al., 1996; Mott et al., 1996; Zhou et al., 2002) . There is also evidence suggesting that the CRD is used as a secondary binding site for isoprenylated RAS subsequent to RBD binding (Brtva et al., 1995; Hu et al., 1995; Luo et al., 1997; Roy et al., 1997; Williams et al., 2000) . The actual role of this interaction is unclear, although displacement of 14-3-3 protein dimers bound to the CRD or in the vicinity has been suggested (Rommel et al., 1996) . The binding of RAS to the CRD may also disrupt an inhibitory interaction between the CRD and the catalytic domain of RAF (Cutler et al., 1998) . The CR2 is defined as a Ser/Thr-rich region that includes an inhibitory 14-3-3 binding site (centered on serine 259 [S259] in C-RAF) (Muslin et al., 1996) . Protein kinases such as Akt1 and protein kinase A have been shown to phosphorylate this site in C-RAF and negatively regulate its activity (Zimmermann and Moelling, 1999; Dhillon et al., 2002b; Dumaz and Marais, 2003) . Conversely, mutation of this site increases the levels of membrane-associated RAF proteins and correlates with increased catalytic activity. Consistent with this model, genetic evidences obtained in Drosophila and C. elegans demonstrated a negative role played by their S259-like residue (Rommel et al., 1997; Chong et al., 2001) . Situated in the C-terminal half of the protein, the CR3 corresponds to the kinase domain. It is immediately followed by a short stretch of amino acids that includes a second highly conserved 14-3-3 binding site (centered on S621 in C-RAF) that is essential for catalytic function (Muslin et al., 1996; Morrison et al., 1993) .
Deconstructing RAF activation
The mechanism leading to RAF activation is relatively complex and only partially solved. Recent advances on this topic are nonetheless providing a conceptual framework that should lead to its elucidation in a near future. Although some distinctions exist among the regulatory modes of RAF isozymes, a similar principle appears to govern their activation (Dhillon and Kolch, 2002; Chong et al., 2003) . In unstimulated cells, RAF proteins are held in the cytoplasm in a catalytically inactive state by a mechanism that involves the binding of 14-3-3 proteins to the conserved N-terminal binding site. Upon growth factor stimulation, RAF relocalizes to membrane compartments where it associates with GTP-loaded RAS through a direct contact between its RBD and the effector loop of RAS. It is unclear however if the relocalization of RAF to activated RAScontaining membranes occurs through a passive diffusion mechanism or whether it is a regulated event that involves a transport machinery. Nonetheless, the role of RAS is not limited to membrane targeting. RAS binding is required to displace 14-3-3 from the N-terminal binding site, thus exposing the motif for growth are depicted with their amino acid length indicated to the right. Human A-RAF is not shown. The RBD, the CRD, the S/T-rich domain and the kinase domain correspond to three CR common to all RAF family members. Critical phosphorylation sites in C-RAF that have demonstrated negative (red) or positive (green) influence are shown. These sites are located in four key areas: (1) the N-terminal 14-3-3-binding site within the S/T domain; (2) the negatively charged N-region (N-r); (3) the kinase domain activation segment (a.s.); and (4) the C-terminal 14-3-3-binding site. Although they have not all been experimentally assessed, residues at identical position in the other RAF isoforms and which presumably function similarly, are also shown. Phospho-mimetic residues are indicated in blue, whereas nonconserved residues are shown in black. (b) Alignment of the amino-acid stretch encompassing the N-region of RAF isoforms. Their respective position is indicated to the left. Inverted triangles indicate the position of C-RAF S338-and Y341-like residues. Phosphomimetic residues are shown in blue. Residue conservation is highlighted in black (100% identity) or in gray (partial identity or similarity). (c) Amino-acid sequence alignment corresponding to the kinase domain activation segment situated between subdomains VII and VIII of RAF isoforms. Inverted triangles indicate the position of C-RAF T491-and S494-like residues.
factor-inducible dephosphorylation. Phosphatases of the PP1 and PP2A families have been linked to this event (Jaumot and Hancock, 2001; Dhillon et al., 2002a; Ory et al., 2003) . The release of 14-3-3 from the N-terminal region coincides with a greater association of RAF to membranes via its CRD and presumably contributes to a conformational change whereby RAF 'opens-up' and exposes its kinase domain for additional regulatory events triggering catalytic activation.
RAS activity has also been found to be required or to synergize with other phosphorylation events that are essential for optimal catalytic activation of RAF. In C-RAF, these events target serine 338 (S338) and tyrosine 341 (Y341) in the so-called negatively charged (N) region lying at the N-terminal boundary of the kinase domain (Fabian et al., 1993; Marais et al., 1995; Mason et al., 1999) , as well as threonine 491 (T491) and serine 494 (S494) in the activation segment situated between sub-domains VII and VIII (Chong et al., 2001 ; Figure 1a ). Although A-RAF appears to depend on the same events (Marais et al., 1997) , B-RAF is distinct in that regard as it only necessitates the phosphorylation of its activation segment presumably because its N region already contains negative charges (Zhang and Guan, 2000) . Indeed, its S338-like residue (S445) is constitutively phosphorylated (Mason et al., 1999) and the Y341-like residue is occupied by a phosphomimetic residue (D447; Figure 1b) . This difference has been invoked to explain why B-RAF has a higher catalytic function compared to the other two mammalian isoforms and also why a single-point mutation in its activation segment is sufficient to convert it into a potent oncogene, a phenomenon that occurs at an impressively high frequency (Davies et al., 2002) . D-RAF and LET-45 have acidic residues at or next to their Y341-like residue (Figure 1b) . It is therefore possible that these homologs are governed by a simpler regulatory mode of activation reminiscent to that of B-RAF. As for their mammalian counterparts, they possess T491-and S494-like residues in their activation segment ( Figure 1c) . Conversion of these residues to acidic ones is sufficient to induce catalytic function (Zhang and Guan, 2000; Douziech et al., 2006) .
Following growth factor stimulation, Src family kinases are suspected to be the major kinase activity responsible for phosphorylating the Y341 residue of C-RAF (Fabian et al., 1993; Marais et al., 1995 Marais et al., , 1997 . The identity of the S338 kinase(s) is not as clear. Although kinases belonging to the PAK family initially appeared as likely contenders, later studies failed to show their ability to respond in a RAS-dependent manner as one would have predicted (Chiloeches et al., 2001) . Interestingly, structural characterization of the B-RAF kinase domain showed that its Y341-like residue (D448) is contacting the R505 residue of helix aC and thus suggests that this interaction is important for stabilizing a productive configuration of this critical helix situated in the N lobe of the kinase domain (Wan et al., 2004) . There is currently no indication as to the role of S338 phosphorylation. Recent work confirmed nonetheless its importance by showing that its specific dephosphorylation by PP5 in vivo inactivates C-RAF catalytic activity (von Kriegsheim et al., 2006) . With respect to the phosphorylation of the activation segment, crystallographic analysis of the B-RAF kinase domain has also provided interesting insights (Wan et al., 2004) . In a B-RAF inactive state, subdomains I (P loop) and VII (DFG motif) are engaged in a hydrophobic interaction that is incompatible with catalysis. Based on their position, it is likely that phosphorylation of the T491-and S494-like residues of B-RAF (T598 and T601) disrupts or prevents this inhibitory interaction and thus leads to an active conformation. Structural determination of B-RAF crystals in a T598-T601 phosphorylated state have yet to be characterized to verify this model. In any case, the finding that close to 90% of all oncogenic mutations in B-RAF targets this area (V599E) is providing compelling support for the importance of this phosphorylation event. The kinase(s) mediating this event has not been identified.
Another aspect that is emerging as a critical step in RAF activation is heterodimerization. Forced dimerization of C-RAF has previously been shown to induce catalytic activity (Farrar et al., 1996; Luo et al., 1996) . Coexpression of B-and C-RAF was subsequently found to induce the formation of a B-/C-RAF complex in a RAS-dependent manner by a mechanism that required 14-3-3-binding at the C-terminal site of C-RAF (Weber et al., 2001 ). However, it was unclear whether RAF dimerization normally occurred and whether it was important for activity. More recently, the formation of a B-/C-RAF complex was shown to stimulate C-RAF catalytic function by a mechanism that occurred even when B-RAF kinase activity is reduced (Wan et al., 2004) . This property was proposed to explain why a number of catalytically impaired B-RAF oncogenic mutations still retained the capacity to stimulate ERK activity when expressed in C-RAF-producing cells. Following up on this work, Kolch and co-workers recently showed that B-/C-RAF oligomers do naturally exist in vivo and that their formation depends on RAS activity (Rushworth et al., 2006) . Most surprisingly and in contrast to recent work published by the group of R Marais (Garnett et al., 2005) , they found that B-RAF catalytic function is dispensable for stimulating wildtype C-RAF and that kinase-inactivated C-RAF can also induce B-RAF catalytic function. Although additional work is required to sort out discrepancies between these studies, it seems that higher order assembly among RAF isoforms allow their respective kinase domain to physically interact with one another, which in turn influences their conformational transition to the active state. The fact that a phosphotransfer reaction does not appear to be required to trigger activation is appealing as it suggests that other types of proteins may directly stimulate RAF catalytic function. Interestingly, a catalytically independent allosteric mechanism has recently been shown to operate in epidermal growth factor receptor (EGFR) transactivation, which most likely explains how a naturally kinase-dead variant, the ErbB3 isoform, activates other EGFR isoforms (Zhang et al., 2006) . A similar mechanism has been suggested to explain the ability of the pseudokinase STRAD to activate the tumor suppressor kinase LKB1 (Boudeau et al., 2006) . Whether RAF activation involves allosterism has not been addressed.
What signals control RAF oligomerization? Are there any other proteins involved? Are there any distinct signaling properties associated to different isoform combinations and are all permutations possible? Answers to these questions and related ones will undoubtedly provide a richer picture surrounding the regulation of RAF activity. Obvious suspects in complex formation are 14-3-3 dimers acting as crosslinkers and several studies already implicate these proteins by their ability to directly contact the C-terminal site of C-RAF. Another possible mode of interaction is via direct contact. Recent data derived from in vitro binding assays suggests that multiple points of contact exist between B-and C-RAF (Rushworth et al., 2006) . However, it is unknown whether these interactions are direct or not. Another study also suggests that a B-RAF-specific region (BRS) located at the Nterminus of B-RAF homologs is important for B-RAF homodimerization as well as for B-/C-RAF heterodimerization and that this activity is regulated by calcium (Terai and Matsuda, 2006) . Finally, other proteins may promote complex formation between B-and C-RAF. For example, the protein kinase Mlk3, a MAPKKK of the Jnk pathway, has unexpectedly been found to participate in B-/C-RAF heterodimer formation (Chadee et al., 2006) .
In addition to proteins mentioned above, there are several others that play important roles regarding RAF function (Kolch, 2000) . Although some appear to play cell-specific or compartment-specific scaffolding functions to permit the assembly of dedicated complexes for precise purposes, like targeting the pathway to endosomes or cytoskeletal structures, others seem to play more basic regulatory roles (Kolch, 2005) . In the next section and through the angle of studies carried out in Drosophila and C. elegans, we present how the characterization of the KSR and CNK scaffolds is contributing to our understanding of the RAF activation process.
KSR proteins
KSR proteins were initially identified in RAS-dependent genetic screens in Drosophila and C. elegans (Kornfeld et al., 1995; Sundaram and Han, 1995; Therrien et al., 1995) . Flies have a single ksr gene that is essential for viability. In addition to its role in various cell differentiation events, clonal analysis of ksr loss-offunction mutations showed cell proliferation and/or survival defects that were reminiscent of mutations in any of the positively required components of the RAS/ ERK module (Therrien et al., 1995) . KSR activity is required downstream of the Torso RTK during the development of the fly embryo extremities as well as downstream of EGFR and Sevenless RTKs during eye development suggesting that it is a general constituent of RTK pathways (Therrien et al., 1995) . Additional support for this conclusion came from a recent study demonstrating that KSR is essential for the development of the air sacs of the dorsal thorax of Drosophila, where its activity is required for EGFR-dependent cell proliferation and breathless (FGF-R)-dependent cell migration (Cabernard and Affolter, 2005) . Interestingly, ksr heterozygous mutations were shown to dominantly suppress RAS V12 activity, but had no impact on a constitutively active D-RAF transgene (Therrien et al., 1995) . These observations suggested that KSR might be acting between RAS and RAF, or in parallel to RAF.
In C. elegans, mutations in the ksr-1 gene were identified as suppressors of a let-60/RAS-mediated multivulva (Muv) phenotype (Kornfeld et al., 1995; Sundaram and Han, 1995) . In contrast to its fly counterpart, ksr-1 is not an essential gene, although loss-of-function mutations led to a weak, but significant larval lethality that was strongly enhanced by mutations in components of the RAS/ERK pathway. Similar observations were made with respect to vulval development. Together, these findings suggested that either KSR-1 activity is redundant with another component or that its role is not as critical as to the one in flies. The subsequent identification of a second ksr gene in C. elegans, ksr-2, that acts redundantly to ksr-1, resolved this issue. Indeed, removal of both genes produced strong let-60-like phenotypes, including a vulvaless phenotype and thereby demonstrated the key role played by KSR activity in RAS-mediated signaling in worms (Ohmachi et al., 2002) .
Evidence that a KSR protein biochemically modulates RAS/ERK signaling was initially obtained using a RAS-dependent assay based on Xenopus oocytes maturation . In this experimental system, expression of a mouse KSR isoform (mKSR1) augments ERK activity and accelerates the rate of maturation in a RAS-dependent manner. A formal demonstration that KSR biochemically contributes to RAS-mediated ERK activation was then shown in Drosophila S2 cells by RNA interference (RNAi) and from C. elegans extracts prepared from ksr-1; and ksr-2 mutant animals (Anselmo et al., 2002; Ohmachi et al., 2002; Roy et al., 2002) . Interestingly, RNAi-based experiments in S2 cells positioned KSR downstream of the insulin receptor, and at a step upstream of RAF, thus suggesting that its activity is relevant for RAF activation as genetic studies were suggesting (Anselmo et al., 2002) .
CA1 to CA5 (Figure 2a ). The CA1 is an N-terminal KSR-specific region of about 40 amino acids. A functional role for this area has been originally supported by the isolation of a Drosophila ksr hypomorphic allele that contained a two-amino-acid change in it (Therrien et al., 1995) . The CA1 domain of Drosophila KSR was found to participate in physical interaction with D-RAF (Roy et al., 2002) . However, this region does not seem to be present in C. elegans KSR proteins (Figure 2a ), which suggests that it is either dispensable under certain conditions or that alternative means fulfill its function. The CA2 is a proline-rich stretch, but no role has yet been attributed to this area. The CA3 region is a cysteine-rich atypical C1 domain related to the one found in RAF protein members. C1 domains are found in multiple signaling proteins and often serve as binding sites for lipid second messengers or proteins, which in turn modulate protein relocalization and/or activation (Colon-Gonzalez and Kazanietz, 2006). As in RAF proteins, the CA3 of mKSR1 is essential for membrane targeting/anchoring following growth factor stimulation or RAS activation (Michaud et al., 1997; Zhou et al., 2002) . However, it does not associate with RAS and is not interchangeable with the CRD of C-RAF or the C1 domain of protein kinase C (PKC)g (Zhou et al., 2002) . Structural characterization of the CA3 region of mKSR1 revealed key differences compared to C-RAF or PKCg C1 domains and thus most likely explain their functional dissimilarities (Zhou et al., 2002) . It is still unknown how the CA3 anchors KSR to membrane compartments. No particular lipid has been found to associate to it, although one report suggests a possible interaction with Gbg proteins, which could represent a means for membrane targeting (Bell et al., 1999) . Remarkably, the translocation of mKSR1 to the plasma membrane appears to be regulated by a mechanism related to the one utilized by RAF proteins and involves cytoplasmic retention by 14-3-3-binding to the N-terminus (Muller et al., 2001) . Indeed, Cdc25-associated kinase 1 (C-TAK1), a kinase of the CAMKlike family (Manning et al., 2002) , has been shown to associate constitutively with mKSR1 and to phosphorylate serine 392 (S392). This residue is part of a 14-3-3 consensus binding site and thus its phosphorylation and C. elegans KSR-1 and KSR-2 are represented with their amino-acid length indicated to the right. Mouse KSR2 has not been described previously and is derived from a computationally predicted gene (NCBI accession number: XP_997574). Five conserved areas (CA) have been initially recognized in KSR proteins. They correspond to the KSR-specific CA1 domain; a proline (P)-rich stretch; a CRD; a S/T-rich domain; and a putative kinase domain. However, some of these are not present in all isoforms. The negatively acting (red) phosphorylation site (S392) within the mKSR1 N-terminal domain and which binds 14-3-3 is shown. Residues with comparable activity in other isoforms have not been reported. Similarly to RAF proteins, a putative 14-3-3-binding site is located near the C-terminus of several KSR members (highlighted in green). ERK/MAPK docking site (FXFP motif) is also found in the S/T domain of several isoforms. Variant amino-acid residues in kinase subdomains II and VII are indicated in red. (b) Alignment of the amino-acid stretch encompassing the putative N-region of KSR isoforms. Their respective position is indicated to the left. Inverted triangles point to residues at position identical to the critical S338-and Y341 residues within the N-region of C-RAF. Phosphomimetic residues are shown in blue. Residue conservation is highlighted in black (100% identity) or in grey (partial identity or similarity). (c) Amino-acid sequence alignment corresponding to the putative activation segment (between subdomains VII and VIII) of the kinase domain of KSR proteins. Inverted triangles point to S/T residues at position similar to phospho-activating residues within the activation segment of C-RAF.
Kinase-independent regulation of RAF activation A Clapéron and M Therrien induces 14-3-3-binding. Conversely, growth factor stimulation correlates with pS392 dephosphorylation in a PP2A-dependent manner, which in turn releases 14-3-3 and promotes mKSR1 membrane attachment (Muller et al., 2001) . It thus appears that the recruitment of mKSR1 to membrane compartments is a dynamic process that depends on a C-TAK1/PP2A regulatory mechanism. Membrane recruitment of KSR in model organisms has not been investigated biochemically, but genetic evidences in C. elegans conclusively showed that PAR-1, a C-TAK1 homolog, antagonizes signaling at the level of KSR-1 (Kao et al., 2004; Yoder et al., 2004) . A positive role in RAS/ERK signaling has also been demonstrated for PP2A in both C. elegans and Drosophila, although the situation is not simple as PP2A probably acts on multiple substrates and a specific influence on KSR itself has not been documented (Wassarman et al., 1996; Kao et al., 2004; Yoder et al., 2004) . With respect to 14-3-3 proteins, genetic studies have been conducted only in Drosophila. The two isoforms in flies, e and z, have so far only been shown to promote RTK-induced RAS/ERK signaling (Chang and Rubin, 1997; Li et al., 1997) . No studies have examined whether Drosophila KSR associates with 14-3-3 proteins. Although artificial, C. elegans KSR-1 was found to associate with human 14-3-3z in a yeast two-hybrid-binding assay (Xing et al., 1997) and thus suggests that 14-3-3-binding is not exclusive to mKSR1.
The CA4 of KSR members is a serine/threonine (S/ T)-rich region that often includes an FXFP motif. This motif, also known as a DEF (docking site for ERK, FXFP) domain, can serve as a docking site for ERK/ MAPK Jacobs et al., 1999) . Consistent with this possibility, mKSR1 was found to associate with ERK in a RAS-dependent manner and this interaction required the CA4 region (Cacace et al., 1999; Muller et al., 2001) . The role of this signaldependent interaction has, however, not been determined. Finally, the CA5 region mostly accounts for the C-terminal half of KSR proteins and corresponds to a kinase domain. This domain is closely related to the kinase domain of RAF proteins, which together are part of the larger tyrosine kinase-like (TKL) family (Manning et al., 2002) . Interestingly, KSR proteins have a domain composition and organization similar to RAF proteins (Figures 1 and 2 ). As mentioned above, they interact with 14-3-3 proteins and their membrane relocalization seems to proceed by a mechanism analogous to the one identified for RAF proteins. KSR members also have a sequence following their kinase domain that resembles a 14-3-3 binding site (Figure 2a ). Whether this motif interacts with 14-3-3 and whether it plays any role remains to be addressed. The structural relationships between KSR and RAF proteins indicate that they probably arise from an ancestral gene duplication event. Given the strong amino-acid sequence conservation between the kinase domain of KSR and RAF proteins (Therrien et al., 1995) , it is possible that phosphorylation events also regulate the structural conformation of the kinase domain of KSR. This possibility remains speculative as no data is currently available on this matter. It is nonetheless interesting that the putative N-region and activation segment of KSR proteins contain putative phosphorylation sites at positions similar to the ones found in RAF (Figure 2b and c) .
There are a number of distinctions between KSR and RAF proteins, which suggest that their specific implication in RAS/ERK signaling is not the same. First, RAF proteins do not have sequences related to the CA1 region. Second, KSR members do not contain a RBD and no direct interaction with RAS has been reported thus far. Third, several studies have failed to detect kinase activity from KSR proteins Michaud et al., 1997; Denouel-Galy et al., 1998; Sugimoto et al., 1998; Yu et al., 1998; Stewart et al., 1999) . However, this point has been a matter of debate as other groups did report kinase activity for mKSR1 (Zhang et al., 1997; Yan and Polk, 2001 ). Catalytic activity from mammalian KSR proteins is unexpected as their kinase subdomain II contains an arginine residue in place of a highly invariant lysine residue (Figure 2a ). This lysine residue is apparently required to orient ATP (Robinson et al., 1996) , and no other residue at this position, including a conservative arginine residue, seem to complement it (Hanks et al., 1988) . Although adjacent lysine residues in some other kinases have been found to execute this function (Xu et al., 2000) , mammalian KSRs do not have lysine residues in the vicinity. On the other hand, C. elegans KSR-1 and Drosophila KSR have the conserved lysine residue in their subdomain II and therefore offered the possibility to test its relevance. Consistent with a noncatalytic role, replacement of this lysine to a methionine in C. elegans KSR-1 did not prevent its ability to rescue a ksr-1 loss-of-function (Stewart et al., 1999) . The same mutation in Drosophila KSR only slightly reduced the activity of the mutant protein to positively contribute to RAS/ERK signaling (Roy et al., 2002) . Although it remains possible that KSRs do have a catalytic activity based on a novel mechanistic principle, they are now generally referred to as pseudokinases (Boudeau et al., 2006) . Finally, a fourth distinction between KSR and RAF proteins is the ability of KSR to stably associate with MEK (DenouelGaly et al., 1998; Yu et al., 1998; Roy et al., 2002; Channavajhala et al., 2005) . The interaction is mediated by the kinase domain of KSR proteins and appears to be constitutive.
KSR proteins link components of the ERK module
Most ksr loss-of-function mutations identified in model organisms targeted the kinase domain (Kornfeld et al., 1995; Sundaram and Han, 1995; Therrien et al., 1995) and thus suggested a key role for this domain. However, because of evidence against standard catalytic function, other possible functions have been explored. Several studies found that mKSR1 associates with the core kinases of the ERK pathway as well as with several regulatory proteins, including 14-3-3, p50/Cdc37 and Hsp90 Xing et al., 1997; DenouelGaly et al., 1998; Yu et al., 1998; Bell et al., 1999; Cacace et al., 1999; Stewart et al., 1999) . Moreover, expression of mKSR1 has been found to shift monomeric MEK to a large KSR/MEK-containing complex, whereas single amino acid changes in the kinase domain based on C. elegans loss-of-function mutations, disrupted MEK binding and prevented complex formation (Stewart et al., 1999) . Likewise, high molecular weight complexes containing mKSR1, MEK and ERK, which could be detected in normal mouse brain lysates, did not appear to form when prepared from mKSR1-deficient mice, thus providing in vivo evidence for the ability of KSR to induce the formation of higher order complexes of the ERK module (Nguyen et al., 2002) . Together, these findings indicated that KSRs may act as scaffolds that assemble the kinases of the ERK pathway. A demonstration that KSR genuinely acts as a scaffold has been provided in Drosophila S2 cells where it was found to bridge RAF and MEK by its ability to associate independently with either protein (Roy et al., 2002) . This specific function has not been demonstrated for mKSR1, although this seems likely given its ability to associate with RAF, MEK and ERK, and to promote the formation of large molecular weight complexes.
Intriguingly, the modality of the interaction observed for Drosophila KSR seemed to differ from the one identified with mKSR1. Although Drosophila KSR associates with RAF and links it to MEK independently of a RAS signal, mKSR1 interacts with C-RAF only in a signal-dependent manner Xing et al., 1997) . The reason behind this divergence has not been addressed, but may reflect intrinsic differences between isoforms and/or cell-specific variations caused by additional proteins. Characterization of the KSR/ RAF association in flies showed that the CA1 and the kinase domain of KSR are required for proper interaction with RAF (Roy et al., 2002) and, as described below, also involved other proteins. In contrast, little is known about the mKSR1/C-RAF interaction except that it involves the kinase domain of mKSR1 and does not appear to depend on 14-3-3 Xing et al., 1997) . Given the closer homology between D-RAF and B-RAF, it would be interesting to test whether B-RAF could associate with mKSR1 irrespective of a RAS signal.
The scaffolding property of KSR is predicted to increase signaling efficiency within the ERK module. Consistent with this view, mutations that reduce or eliminate the interaction with MEK or RAF behave as loss-of-functions (Stewart et al., 1999; Muller et al., 2000; Roy et al., 2002) . However, one question persists. Does KSR only act as a scaffold? As mentioned above, previous work conducted in Drosophila found that ksr mutations suppressed RAS gain-of-function activity, but had no impact on constitutively active RAF (Therrien et al., 1995) . A hypothesis accounting for these results would be that KSR is acting upstream of RAF. In agreement with this idea, a biochemical study using an RNAi knockdown approach found that depletion of endogenous KSR in S2 cells decreased insulin-induced RAF catalytic activity (Anselmo et al., 2002) . Although this does not rule out the possibility that KSR also plays a scaffolding function upstream of RAF, it indicated that KSR is relevant for RAF activity and that the characterization of this function may shed light on the RAF activation mechanism. Recent work on this topic suggests that Drosophila KSR indeed participates in RAS-dependent RAF activation. However, this function appears to involve another evolutionarily conserved protein known as CNK.
CNK: a regulator of RAF activation
Expression of the isolated kinase domain of Drosophila KSR during eye development impairs RAS-dependent cell differentiation owing to its presumed ability to uncouple MEK from RAF . This dominant-negative effect produces a scorable rough eye phenotype in adult flies that was used in a modifier screen to identify functional partners of KSR and which led to the isolation of loss-of-function mutations in the cnk locus as enhancers of the phenotype (Therrien et al., 1998) . As ksr alleles, cnk mutations suppressed RTK or RAS gain-of-function activity, but had no effect on a constitutively active RAF, and thus suggested that cnk is also required upstream of RAF (Therrien et al., 1998) . Functional analysis of cnk revealed that its activity is not restricted to eye development, but is operating in other RTK-mediated developmental events affecting cell proliferation/survival, differentiation and migration, and thereby implied a general role for CNK in Drosophila RTK signaling (Therrien et al., 1998; Baonza et al., 2000; Cabernard and Affolter, 2005) . Initial characterization of the CNK protein revealed its ability to interact with RAF, which suggested that it directly regulates RAF (Therrien et al., 1998) . Consistent with this possibility, depletion of CNK by RNAi in Drosophila S2 cells decreased RAF catalytic activity (Anselmo et al., 2002) . Interestingly, this effect also correlated with a significant reduction of RAF in membrane-containing fractions and thus raised the possibility that CNK participates in RAF compartmentalization. However, this property has not been further investigated.
No mutation in the unique cnk-1 gene in C. elegans has been recovered through RAS-dependent genetic screens. To verify its putative role in RAS signaling, a recent study used a reverse genetic approach and characterized cnk-1 deletion alleles that had been generated in an unbiased way (Rocheleau et al., 2005) . Unlike in Drosophila, cnk-1 is not essential for viability and its elimination did not result in let-60-like phenotypes. However, unambiguous genetic interactions were observed when mutant alleles were combined to heterozygous mutations in other components of the pathway and thus indicated that even though it is not a critical component of the RAS/ERK pathway in worms, it does play a role. Furthermore, epistatic analyses were consistent with findings obtained in flies and positioned CNK-1 at a step leading to the activation of LIN-45/ RAF. Interestingly, there seemed to be no obligate interdependency between CNK and KSR proteins as cnk-1 interacted genetically with ksr-1, but not with ksr-2. Moreover, cnk-1 alleles produced distinct RAS-like phenotypes depending on whether they were tested in a ksr-1 or sur-8 mutant background. The sur-8 locus encodes another scaffold protein that bridges RAS and RAF in C. elegans (Sieburth et al., 1998) . Therefore, the ability of CNK-1 to have specific effects depending on the genetic status of other scaffolds suggests that CNK proteins may take part of distinct protein complexes.
Mammalian CNK homologs are involved in multiple GTPase-regulated signaling events
Like most components regulating RAS/ERK signals, CNK homologs are found in other metazoans. At least three genes encode CNK-related proteins in mammals (Figure 3 ). For simplicity, they are referred to as CNK1, CNK2 and CNK3. CNK2 has also been named Membrane-Associated GUanylate kinase INteracting protein (MAGUIN) owing to the ability of a rat isoform to associate with membrane-associated neuronal proteins (Yao et al., 1999) . CNK2 is the closest homolog to fly and worm CNK and thus likely represents the orthologous member. Two splicing variants for CNK2 have been identified. They encode two related isoforms, CNK2A and CNK2B, which have distinct C-termini. CNK2A contains a PDZ domain-binding motif at its C-terminus (ETHV) that has been found to associate with specific PDZ domains of Densin-180, S-SCAM and PSD-95 and is therefore thought to play a role in the assembly of a postsynaptic protein complex (Yao et al., 1999; Ohtakara et al., 2002) . Two variants have also been identified for CNK3, namely, CNK3A and CNK3B (Douziech et al., 2003) . However, it is currently unclear whether they originate from a single gene or they are in fact encoded by two independent loci. They respectively correspond to the N-terminal and C-terminal halves of a hypothetical full-length CNK protein (Figure 3) . Their loci are next to each other and spaced by less than 80 kb of DNA on the same human or mouse chromosome. However, even though the polarity of their transcriptional unit is in the right orientation, no overlapping transcripts have been identified and gene annotation programs identified them as independent loci (MapView; NCBI). CNK3B is also known as PIP-3E and was identified in a screen for protein associating with specific phosphoinositides (Krugmann et al., 2002) . It was also identified in a yeast two-hybrid screen as a cytohesin-binding protein and named interaction protein for cytohesin exchange factor 1 (IPCEF1; (Venkateswarlu, 2003) .
A few studies have now begun to address the role of CNK proteins in mammalian tissue culture cells (summarized in Table 1 ). Clearly, CNK1 and CNK2 do regulate RTK-induced RAS/ERK signal transduction and, as for Drosophila CNK, they associate with RAF (Yao et al., 2000; Lanigan et al., 2003; Bumeister et al., 2004; Ziogas et al., 2005) . However, they also appear to have additional functions that have not yet been observed in model organisms. For instance, human CNK1 (hCNK1) was shown to act as a scaffold in a Rho-dependent JNK pathway owing to its ability to link together several components of this pathway, including Figure 3 Domain organization of CNK isoforms. Drosophila (Dmel), C. elegans (Ce) and human (h) CNK homologs are proportionally depicted with their conserved domains or regions (colored boxes; see text for detailed description) and their respective amino-acid length is indicated to the left. P denotes proline-rich area. Alternative names for some of the mammalian homologs are also provided. The RIM and IS of Drosophila CNK forms the so-called RAF-inhibitory region. Next to it lies a Src42-binding site centered on the Y 1163 ELI residues and which releases, upon binding, the inhibitory effect of the IS element on RAF. Short motifs with similar activities in other CNK homologs have not yet been reported. Bracketed CNK2 proteins denote splicing variants originating from the same gene. CNK2A ends with a PDZ domain-binding motif that is required for interactions with Densin-180, PSD-95 and S-SCAM (see Table 1 ). CNK3A and CNK3B represent N-and C-terminal parts of a full-length CNK protein, respectively. Although they are encoded by independent transcripts, and thus most likely exist independently from one another, the proximity and respective polarity of their associated genes indicate that they potentially arise from the same gene (dashed bracket). See text for further details.
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RhoGEFs, MLK2/3 and MKK7 (Jaffe et al., 2004 (Jaffe et al., , 2005 . There is also evidence that hCNK1 plays a similar role in a Rac-dependent Jnk pathway (Jaffe et al., 2005) . Intriguingly, hCNK1 was reported to contribute to a RAS-mediated cell death mechanism by its ability to couple the tumor suppressor RASSF1A and the proapoptotic kinases MST1/2 (Rabizadeh et al., 2004) . It is not clear, however, whether this scaffolding role is normally taking place in vivo. hCNK1 was also found to associate with RalGDS, a GEF for RalA/B (Jaffe et al., 2004) , or with the angiotensin II type 2 (AT 2 ) receptor (Fritz and Radziwill, 2005) , but no functional event has been connected to these interactions. An association between hCNK2 and Rlf, another GEF for Ral GTPases, has also been observed, but again a functional impact on the RAL themselves has not been demonstrated (Lanigan et al., 2003) . The role of hCNK2 in RTK-mediated events has been examined in PC12 cells. In those cells, EGF stimulation is known to transiently activate ERK, which in turn induces cell proliferation. In contrast, nerve growth factor (NGF) treatment results in sustained ERK activation that is correlated with a block in cell proliferation and induction of a neuronal-like cell differentiation program that is characterized by the appearance of neurite extensions (Vaudry et al., 2002) . Interestingly, knockdown of hCNK2 in PC12 cells did not affect EGF stimulation, but prevented NGF-dependent ERK activation as well as neurite outgrowth (Bumeister et al., 2004) . Moreover, this work revealed that hCNK2 also acts in parallel to ERK signals to regulate neurite formation. It thus appears that CNK proteins can mediate RTK-specific signals and that their function is not restricted to RAS/ ERK signaling. Another example of an RTK-stimulated function that is ERK independent is provided by CNK3B/IPCEF1. Interestingly, a rat homolog was shown to associate with several cytohesins, which are GEFs for Arf GTPases (Venkateswarlu, 2003) . Characterization of an IPCEF1/Cytohesin 2 complex revealed that the two proteins associate in the cytoplasm. EGF stimulation induces plasma membrane relocalization of IPCEF1 in a cytohesin 2-dependent manner, which led to increased cytohesin 2 GEF activity towards Arf6, a small GTPase involved in vesicular trafficking and cytoskeletal changes. It is remarkable that a limited set of studies readily linked mammalian CNK proteins to five different GTPases, namely, Ras, Rho, Rac, Ral and Arf. As this may represent a specific characteristic of this protein family, it would be interesting to determine whether other GTPase-dependent events are also controlled by CNK proteins. They may indeed act as general regulators of GTPase-mediated events that dictate which particular pathway a GTPase will utilize in a given cellular context by their ability to assemble specific protein complexes. Kinase-independent regulation of RAF activation A Clapéron and M Therrien
CNK proteins are multidomain-containing scaffolds
Primary amino-acid sequence comparison of CNK homologs identified three protein-protein or proteinlipid interaction domains, indicating that they probably act as lipid-regulated scaffolds (Figure 3 ). They contain a sterile alpha motif (Tsuda et al., 1993) domain located at the N-terminus, followed by a PSD-95/DLG-1/ZO-1 (PDZ) domain and then a pleckstrin homology (PH) domain. SAM domains are found in a wide variety of proteins, but only a handful have been characterized (Qiao and Bowie, 2005) . Three distinct properties have been assigned to these domains. They can homo-or hetero-oligomerize; bind to specific RNAs; or associate with membrane lipids. With respect to CNKs, only the SAM domain of Drosophila CNK has been functionally studied. It is essential for fly viability as well as for RASmediated ERK activation in S2 cells (Douziech et al., 2003 (Douziech et al., , 2006 and recent work revealed its ability to associate with another SAM domain-containing protein (see below). PDZ domains also represent a prevalent class of domains in signaling proteins (Nourry et al., 2003) . A number of those specifically bind to the C-terminal extremity of their target proteins. Some have also been shown to associate with other PDZ domains or to phosphoinositides. No specific role or binding partner has been assigned to any of the PDZ domain found in CNK proteins. Finally, PH domains are mostly known for their ability to interact with phosphoinositides and thereby may act as signal-activated membrane anchoring modules (Lemmon, 2004) . The ability of CNK3B/PIP3-E to bind phosphatidylinositol (3,4,5)-trisphosphate (PIP 3 ) suggests such a role for the PH domain of CNK proteins. PH domains can also interact with proteins and, interestingly, the PH domain of hCNK1 has been found to associate with activated RHO (Rho L63 ) or GTP-bound wild-type Rho (Jaffe et al., 2004) . This interaction is consistent with the implication of hCNK1 in a Rho-dependent JNK pathway.
In addition to the domains mentioned above, CNK proteins contain a number of short motifs, such as proline-rich stretches and tyrosine residues within consensus binding sites for SH2 domains as well as longer CRs that possibly fulfill important signaling functions (Therrien et al., 1998; Figure 3) . A notable example is the area between the SAM and PDZ domains and which has been named conserved region in CNK (CRIC). The relevance of this region of approximately, 80 amino acids was initially supported by the identification of a loss-of-function mutation affecting it in Drosophila CNK (Therrien et al., 1998) . Subsequent work confirmed its functional importance in RAS/ERK signaling, but its molecular role has not been elucidated. Notably, the CRIC of hCNK1 has been reported to associate with MLK2/3, rhophilin, and the AT 2 receptor, and thus presumably serves as a binding interface for other proteins. Another CRIC proteins is found near their C-terminal extremity (Figure 3 ). This area, named conserved region among chordate (CRAC), is absent in Drosophila and C. elegans CNK, and seems restricted to CNK isoforms found in chordates (Douziech et al., 2003) . This region is required for the interaction of CNK3B/IPCEF1 to a coiled-coil motif of cytohesin 2 (Venkateswarlu, 2003) , and thus suggests that it is a binding surface. In agreement with their structural organization, the ability of CNK proteins to interact with several distinct proteins indicates that they probably assemble various types of protein complexes, which most likely translate into distinct signaling outputs.
Drosophila CNK assembles an RTK-regulated RAF-activating complex Given its essential role in RTK-induced RAF activation in Drosophila, characterization of CNK in this system offered the opportunity to unveil novel features relevant for RAF activation. CNK directly associates with the kinase domain of RAF via a short amino-acid sequence, called the RAF-interacting motif (RIM), and modulates RAF activity according to the RTK signaling status (Douziech et al., 2003; Laberge et al., 2005; Figure 4) . Without RTK signals, CNK-bound RAF is inhibited by a second motif adjacent to the RIM, called the inhibitory sequence (IS). Upon RTK activation, CNK integrates Src and RAS activities, which then lead to RAF activation. How CNK is integrating these two signals is now partly understood. The binding of Src42 (a Src family kinase) to an RTK-dependent phospho-tyrosine residue (pY1163) located at the C-terminal of the IS motif appears to release the inhibitory effect that the IS motif imposes on RAF catalytic function (Laberge et al., 2005) . This event, which does not require Src42 kinase activity, presumably renders RAF responsive to RAS-dependent signals. Surprisingly, in addition to acting through the RBD of RAF, RAS-mediated RAF activation in fly cells strongly depends on the SAM and CRIC domains of CNK (Douziech et al., 2003) . A role for the SAM domain has recently been suggested. Indeed, it was found to associate with a novel protein of 106 amino acids that essentially consists of a SAM domain. This protein has been independently identified by two groups and named hyphen (HYP) or aveugle (Ave) (Douziech et al., 2006; Roignant et al., 2006) . Functional characterization of HYP/AVE (referred to as HYP thereafter) indicated that it acts downstream of RAS, but at a step upstream of RAF. Furthermore, analysis of loss-offunction mutations confirmed its role downstream of EGFR during eye and wing development (Roignant et al., 2006) . HYP presumably functions downstream of other RTKs as it has recently been identified in a cell-based genome-wide RNAi screen for genes required for ERK activation induced by various RTKs, including the Insulin receptor and a homolog of the plateletderived growth factor/vascular endothelial growth factor receptor (Friedman and Perrimon, 2006) . A single homolog has been identified in C. elegans, whereas mammals contain at least two related proteins (Douziech et al., 2006; Roignant et al., 2006) . Therefore, its function is presumably conserved in other metazoans. Remarkably, biochemical characterization of the presumed SAM CNK /SAM HYP heterodimer showed that it facilitates the recruitment of a KSR/MEK complex to CNK and as a result bridges KSR/MEK to RAF (Douziech et al., 2006) . Interestingly, the binding of KSR/MEK to CNK/HYP strongly augments RASmediated RAF activation. This later event also depends on the CRIC domain whose molecular role has not been determined. Altogether, these findings provided a molecular explanation tying together CNK and KSR and unveiled a network of protein-protein interaction orchestrated by CNK that enabled RTK-induced RAF activation.
The ability of Drosophila CNK to actively repress RAF catalytic function in absence of upstream signals is interesting and may be used, as shown for other scaffolds, to confine activation temporally and/or spatially (Dard and Peter, 2006) . Alternatively, it may be required to prevent signal-independent MEK activation in a context where RAF is assembled in close proximity to its activator and substrate. More interestingly, it may be part of a signal integrator device to produce specific signaling events. For example, only receptors activating RAS and inducing the phosphorylation of the Y1163 residue of CNK may activate CNKbound RAF. It is currently unclear whether mammalian CNKs operate in a similar manner, but a number of elements are compatible with this possibility. hCNK1 (1) phosphorylation of the Y1163 residue (YELI motif) triggers Src42-binding and release of the IS effect on RAF (blunted gray bar); (2) RAS activity through the SAM/CRIC domains (not depicted). How RAS activity is perceived and implemented has not been determined. Classic RAS effect through the RAF RBD is also essential for optimal RAF activation. Following the reception of the aforementioned signals, KSR comes into play. The model shown here suggests that KSR allosterically induces conformational changes in RAF that not only stabilizes an 'open' configuration whereby its N-terminal domain no longer interacts with the kinase domain (possibly depends on the CA1 domain), but also promotes the transition of the kinase domain to the active state (gray arrow). Phosphorylation of the activation segment of RAF, possibly by another conformationally active RAF molecule, would then stabilize the active state and lead to MEK/ERK phosphorylation cascade.
Kinase-independent regulation of RAF activation A Clapéron and M Therrien and 2 associate with B-and C-RAF isoforms (Yao et al., 2000; Lanigan et al., 2003; Ziogas et al., 2005) and overexpression of hCNK2 in mammalian cells represses RAS-induced ERK activity (Lanigan et al., 2003) . Furthermore, recent findings suggest that hCNK1 links C-RAF and Src and thereby enables Src-mediated phosphorylation of the Y341 residue of C-RAF (Ziogas et al., 2005) . As C-RAF is apparently not preassociated to hCNK1, but requires a RAS signal to do so, it is unclear whether the inhibitory effect is relevant in this case. However, B-RAF was found to bind hCNK1 independently of RAS (Ziogas et al., 2005) . If this interaction is inhibitory to B-RAF, it would be interesting to verify whether a Src-binding mechanism analogous to the one described in Drosophila releases inhibition. The PC12 cell model might be appropriate to explore this possibility as their NGF-induced differentiation depends on Src, B-RAF and CNK2 (Kremer et al., 1991; Vaillancourt et al., 1994; Bumeister et al., 2004) .
Is KSR a direct activator of RAF?
KSR stably associates with MEK and thereby serves as a means to recruit MEK to RAF. Although essential, this function does not appear to be the only role for KSR. Indeed, recent findings suggest that KSR activity is required at a step after the release of 14-3-3 bound at the N-terminus of RAF, but before the phosphorylation of the activation segment (Douziech et al., 2006) . Moreover, this function was found to be independent of its ability to bridge RAF and MEK. Most surprisingly, overexpression of KSR, RAF and MEK in S2 cells was shown to induce MEK phosphorylation independently of endogenous RAS and CNK as if a RAF-activating property is being unmasked under those conditions. In contrast, RAS or CNK require KSR to stimulate RAF (Douziech et al., 2006) . Three simple scenarios may account for the RAF-activating function of KSR. First, KSR may recruit a RAF activator or sequester a RAF inhibitor. Second, KSR is perhaps a bona fide kinase that directly phosphorylates the a.s. of RAF. However, one would have to invoke a novel mode of phosphotransfer reaction. Third, KSR might be an allosteric inducer of RAF catalytic function. In this model, activity does not depend on a putative catalytic function, but on the ability of KSR to regulate the conformation of the catalytic domain of RAF. Variations on these three models could also be envisioned. Nonetheless, given strong structural similarities between RAF and KSR proteins and the recent demonstrations that catalytically impaired RAF variants retain the capacity to drive RAF activation (Rushworth et al., 2006) , it is likely that Drosophila KSR acts on RAF through a mechanism shared by RAF-like proteins and which does not necessitate catalytic activity (Figure 4) . It is currently unknown whether such a mechanism involves allosterism and structural characterization will be required to address this point. Moreover, there is currently no evidence as to whether mammalian KSR1 and/or KSR2 also display catalytically independent RAF activating properties. This point is important to make as it could means that the number of permutations among RAF-like proteins contributing to RAF activity is greater than expected. Moreover, it would provide additional support to the emerging view that pseudokinases are not inert binding surfaces, but are actively involved in signal-transduction processes (Boudeau et al., 2006) .
Although under normal conditions RAS binding to the RBD is essential for RAF activation, it appears that in fly cells RAS also acts through the SAM and CRIC domain of CNK to activate RAF (Douziech et al., 2003; Douziech et al., 2006) . The reason behind this requirement is currently unknown, although it may reflect the regulation of CNK-bound KSR by RAS. For example, if 14-3-3 binds to the N-terminal domain of KSR to keep it in an unproductive conformation, a RAS-dependent event may be required to remove 14-3-3 and thereby allows KSR to execute its role. The finding that mKSR1 also requires RAS input to get rid of an inhibitory interaction with Impedes Mitogenic signal Propagation (IMP), an E3 ubiquitin ligase that sequesters KSR in a Triton-insoluble compartment (Matheny et al., 2004) , represents another possible regulatory event that could explain RAS dependency of CNK-bound KSR. Similarly, the CRIC domain may interact with another key protein in a RAS-dependent manner or whose activity is regulated by RAS. Alternatively, the CRIC may be a RAS-responsive structural element that directly modulates the RAF-activating function of KSR.
Concluding remarks
Although RAF has been identified over 20 years ago, it is only recently that a unified picture of its complex activation process has emerged. Solving this issue is not a futile exercise considering the fact that RAF is a major effector of oncogenic RAS. Furthermore, the recent recognition that close to 70% of human melanomas as well as several other types of tumors have activating mutations in the B-RAF gene has revived much interest in deciphering its regulation and identifying ways to interfere with its downstream effects (Wellbrock et al., 2004; Gollob et al., 2006) . In this context, any new information regarding how RAF activation is taking place or how its activity is transmitted to downstream substrates such as MEK, may translate into highly valuable targets, tools or concepts for anticancer therapeutic intervention. The characterization of KSR and CNK proteins may therefore contribute significantly in that respect. For example, small compounds that selectively impair key interactions may prove beneficial. Alternatively, drugs mimicking ISs such as the one identified in CNK may be even more useful as they may also act on RAF gain-of-function mutations. Finally, the use of model organisms not only as discovery tools, but also as experimental systems to address specific mechanistic questions pertaining to RAS/ERK signaling represent effective approaches complementary to mammalian systems to help unravel the molecular intricacies inherent to this pathway. The recent finding that over 80 genes are apparently required for RAS-induced ERK activation in fly S2 cells (Friedman and Perrimon, 2006) further emphasizes the importance of exploiting simple metazoan systems. However, it also begs for innovative methodologies to experimentally approach this dramatic increase in pathway complexity.
